Blackstone Inc
DYN icon

Blackstone Inc’s Dyne Therapeutics DYN Stock Holding History

Blackstone Inc’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$501K Sell
22,578
-34,529
-60% -$642K ﹤0.01% 355
2026
Q1 		$1.04M Buy
+57,107
New +$985K ﹤0.01% 240

Other funds holding DYN

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Blackstone Inc's DYN Position: Q2 2026 in Review

Blackstone Inc reduced its Dyne Therapeutics (DYN) stake by 60% in Q2 2026, selling an estimated $642K and leaving 22,578 shares worth $501K. The position accounts for ﹤0.01% of the portfolio, ranked #355.

Blackstone Inc first reported a position in DYN in Q1 2026 and has held it in 2 quarters since. The position peaked at $1.04M in Q1 2026. 245 funds tracked by Wall St. Rank hold DYN as of Q2 2026.

  • Blackstone Inc held 22,578 shares of Dyne Therapeutics worth $501K as of Q2 2026.
  • Blackstone Inc sold 34,529 Dyne Therapeutics shares in Q2 2026, an estimated $642K.
  • Dyne Therapeutics made up ﹤0.01% of Blackstone Inc's portfolio in Q2 2026, its #355 holding.
  • Blackstone Inc first reported a position in Dyne Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • Blackstone Inc's Dyne Therapeutics position peaked at $1.04M in Q1 2026.
  • 245 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q2 2026.

Based on Blackstone Inc's 13F filing for Q2 2026, filed 14 Aug 2026.